Savitz Adam has filed 19 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 124000 shares of Alto Neuroscience, Inc. ($ANRO) on February 11, 2026.
Activity breakdown: 4 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 124000 | $0.00 | 124,000.0000 | 31,066,335 | 9999.99% | 0.40% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 22481 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.08% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 33008 | $0.00 | 33,008.0000 | 27,072,129 | 9999.99% | 0.12% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 33008 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.12% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 123645 | $0.00 | 123,645.0000 | 27,072,129 | 9999.99% | 0.46% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 123645 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.46% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 73000 | $0.00 | 73,000.0000 | 27,072,129 | 9999.99% | 0.27% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 73000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.27% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 27,072,129 | 9999.99% | 0.28% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 22481 | $0.00 | 22,481.0000 | 27,072,129 | 9999.99% | 0.08% |
| July 3, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | D | Employee Stock Option (Right to Buy) | 76000 | $0.00 | 0.0000 | 27,072,129 | 100.00% | 0.28% |
| Feb. 5, 2025 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 0 | 9999.99% | 0.00% |
| July 9, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 1388 | $13.15 | 36,920.0000 | 0 | 3.91% | 0.00% |
| July 10, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 2931 | $13.22 | 39,851.0000 | 0 | 7.94% | 0.00% |
| July 9, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 10681 | $12.53 | 35,532.0000 | 0 | 42.98% | 0.00% |
| March 1, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | A | Employee Stock Option (Right to Buy) | 73000 | $0.00 | 73,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | C | Common Stock | 7851 | $0.00 | 7,851.0000 | 0 | 9999.99% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | P | Common Stock | 17000 | $16.00 | 24,851.0000 | 0 | 216.53% | 0.00% |
| Feb. 6, 2024 | Alto Neuroscience, Inc. | $ANRO | Savitz Adam | CHIEF MEDICAL OFFICER | C | Series B Preferred Stock | 16666 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |